Est H2’21 sales (£5.4m) jump 17% vs H1’21 (£4.6m)
After a quiet H1 due to the pandemic, Kromek is now enjoying a powerful rebound for its next...
Read moreLatest deal enhances revenues and relationships
The latest acquisition, Midlands based finance broker MAF Property Limited (trades as MAF Finance...
Read moreDirection of travel intact
Ahead of its FY 2021 results in July, RUA Life Sciences’ trading update included its first year...
Read more
M3: another gem in the portfolio
With the recent announcement of the positive Phase 2b clinical study of XF-73 in the prevention of...
Read moreBroadening the scope for growth
UPGS’s success in online and supermarkets, combined with the ability of key brands to resonate with...
Read moreMomentum clearly building
In our Jan 21 initiation note ‘Time to be rerated’ we suggested that Time’s results for H1 to 30...
Read moreRacing ahead of forecasts: our fair value rises
AUM closed FY21 on £9.0bn (+35% y-o-y from £6.7bn) with Tatton reaching this milestone a year ahead...
Read moreWhat a difference a year makes
Destiny has transformed its position, both in fundamental terms and in share price strength. A year...
Read moreIncreased confidence and strategic review
Northbridge’s results for FY20 were in line with market expectations, showing both revenues and...
Read moreAnother leap in AUM, outlook remains positive
AUM reached £30.0bn for the first time on 31 Mar 21 (six months into FY21), up 49% in H1 and 19% in...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
